NCT00003252View on ClinicalTrials.gov

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1997

Study Completion Date

September 30, 2004

Conditions
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

amifostine trihydrate

Trial Locations (1)

60076

Rush North Shore Medical Center, Skokie

All Listed Sponsors
lead

Rush North Shore Medical Center

OTHER

NCT00003252 - Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy | Biotech Hunter | Biotech Hunter